Fine Motor Development of High-Risk Infants at 3,6,12 and 24 Months

1993 ◽  
Vol 13 (1) ◽  
pp. 19-38 ◽  
Author(s):  
Elisabeth Churcher ◽  
Mary Egan ◽  
Wikke Walop ◽  
Pein Pein Huang ◽  
Annabel Booth ◽  
...  
Keyword(s):  
High Risk ◽  
Motor Development ◽  
Fine Motor ◽  
High Risk Infants

scholarly journals Reliability and Concurrent Validity of a Chinese Version of the Alberta Infant Motor Scale Administered to High-Risk Infants in China

2018 ◽  
Vol 2018 ◽  
pp. 1-10 ◽  
Author(s):  
Hui Wang ◽  
Haifeng Li ◽  
Jiangping Wang ◽  
Huiying Jin
Keyword(s):  
High Risk ◽  
Motor Development ◽  
Concurrent Validity ◽  
Physical Therapist ◽  
Intraclass Correlation ◽  
Age Groups ◽  
Reliability And Validity ◽  
Correlation Coefficients ◽  
Fine Motor ◽  
High Risk Infants

The Alberta Infant Motor Scale (AIMS) is widely used to screen for delays in motor development in high-risk infants, but its reliability and validity in Chinese infants have not been investigated. To examine the reliability and concurrent validity of AIMS in high-risk infants aged 0-9 months in China, this single-center study enrolled 50 high-risk infants aged 0-9 months (range, 0.17-9.27; average, 4.14±2.02), who were divided into two groups: 0-3 months (n=23) and 4-9 months (n=27). A physical therapist evaluated the infants with AIMS, with each evaluation video-recorded. To examine interrater reliability, two other evaluators calculated AIMS scores by observing the videos. To measure intrarater reliability, the two evaluators rescored AIMS after >1 month, using the videos. Concurrent validity was assessed by comparing results between AIMS and the Peabody Developmental Motor Scale-2 (PDMS-2). For all age groups analyzed (0-3, 4-9, and 0-9 months), intraclass correlation coefficients (ICCs) for AIMS total score were high for both intrarater comparisons (0.811-0.995) and interrater comparisons (0.982-0.997). AIMS total scores were well correlated with all PDMS-2 subtest scores (ICC=0.751-0.977 for reflexes, stationary, locomotion, grasping, and visual-motor integration subsets). However, the fifth percentile of AIMS total score was only moderately correlated with the gross motor quotient, fine motor quotient, and total motor quotient subtests of PDMS-2 (kappa=0.580, 0.601, and 0.724, respectively). AIMS has acceptable reliability and concurrent validity for screening of motor developmental delay in high-risk infants in China.

Effect of cerebrolysin on neurodevelopmental outcome of high risk preterm infants: A randomized controlled trial

2021 ◽  
pp. 1-9
Author(s):  
A. Samir ◽  
N. Nasef ◽  
K. Fathy ◽  
A-H. El-Gilany ◽  
S. Yahia
Keyword(s):  
High Risk ◽  
Preterm Infants ◽  
Motor Development ◽  
Intervention Program ◽  
Controlled Trial ◽  
Intervention Group ◽  
Fine Motor ◽  
Early Intervention Program ◽  
Gross Motor ◽  
Gross Motor Development

BACKGROUND: A significant proportion of preterm infants experience developmental delay despite receiving a post discharge early interventional care. Cerebrolysin is a peptide mixture which acts similar to endogenous neurotrophic factors through promoting neurogenesis and enhancing neuronal plasticity. OBJECTIVE: To compare the effect of Cerebrolysin plus routine intervention program versus routine intervention program alone on the outcome of preterm infants at high risk for neurodevelopmental delay. METHODS: In a randomized controlled trial, high-risk preterm infants <  32 weeks’ gestation who have abnormal neurological assessment at two months corrected post-natal age were randomized at 6 months corrected post natal age to receive either early intervention program or early intervention program plus Cerebrolysin injection of 0.1 mL/kg body weight every week for 3 months as an adjuvant therapy. The primary outcome was the rate of failure of the gross motor assessment at 12 months of corrected age and secondary outcomes included fine motor, language, and personal social development at 12 months corrected post-natal age as assessed by Denver Developmental Screening Test II. RESULTS: Cerebrolysin group had a significant lower number of infants diagnosed with failed gross motor development compared to infants in the routine intervention group [10 (33%) versus 21 (70%), p = 0.009]. Cerebrolysin group had a significant lower number of infants diagnosed with failed fine motor, language and personal social development compared to infants in the routine intervention group. CONCLUSION: Cerebrolysin, as an adjuvant therapy to routine early interventional care, may improve gross motor development of high-risk preterm infants at 12 months corrected post-natal age.

ACIP Backs Menhibrix for High-Risk Infants

2012 ◽  
Vol 5 (11) ◽  
pp. 24-25
Author(s):  
ELIZABETH MECHCATIE
Keyword(s):  
High Risk ◽  
High Risk Infants
Sign in / Sign up

Export Citation Format

Share Document